This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stockpickr Lists: Pharmion Soars on Trial Results

Editor's Note: In this feature from Stockpickr, we highlight lists of stocks that have made new highs, lows or seen other unusual activity.

Biggest % Gainers: Pharmion (PHRM) soared 58% after the company revealed positive phase III data for its Vidaza, a treatment for high-risk myelodysplastic syndromes. The drug performed well against conventional care regimens in the late-stage trial. Shares were up $14.42 at $439.06.

52-Week Highs: Shares of Pharmion also reached a 52-week high during Thursday trading.

Rising on Unusual Volume: Morningstar (MORN - Get Report) increased 19.9% Thursday amid volume six times its three-month average after it reported very strong second-quarter earnings. Profits rose to $18.3 million, or 38 cents per share, from $11.2 million, or 24 cents per share, during the same quarter in 2006. The stock closed up $9.77 at $58.68.

Biggest % Losers: Pozen (POZN - Get Report) sunk 43% after the Food and Drug Administration said it and partner GlaxoSmithKline (GSK - Get Report) need to collect more safety data on their proposed migraine drug Trexima. The North Carolina-based company lost $7.52 to $9.93.

52-Week Lows: Getty Images (GYI) fell 19% to a 52-week low after it made a forecast for third-quarter profit and sales that fell below Wall Street's expectations. The company, which creates and distributes photos and other images, was down $8.70 at $36.14.

Latest Activist Situations: Ken Griffin's Citadel disclosed a 5.7% stake in Beazer Homes (BZH - Get Report). This is up from the 1.2 million shares the firm held on March 31. Shares closed up 13.5% Thursday to $13.04.

Forum of the Day

What's the best investment at age 18? 03 black gt asks.

Do You Know the Answer?

Is covering long positions with puts feasible for small investors? Corgy asks.

Feeling Lucky?

And finally, try picking a random portfolio suited to do-it-yourselfers with more detailed analysis at I'm Feeling Lucky.
Stockpickr is a wholly owned subsidiary of

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
BZH $14.67 0.00%
EEM $33.94 0.00%
GSK $40.96 0.00%
MORN $81.27 0.00%
POZN $7.28 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs